Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Brain-Derived Neurotrophic Factor and Suicide in Schizophrenia: Critical Role of Neuroprotective Mechanisms as an Emerging Hypothesis.

Shrivastava A, De Sousa A, Rao GP.

Indian J Psychol Med. 2016 Nov-Dec;38(6):499-504. doi: 10.4103/0253-7176.194913. Review.

2.

Suicide in hospitalized early psychosis patients at the time of discharge from hospital: An exploratory study of attempters and nonattempters.

Shrivastava A, Berlemont C, Campbell R, Johnston M, De Sousa A, Shah N.

Indian J Psychiatry. 2016 Apr-Jun;58(2):142-6. doi: 10.4103/0019-5545.183773.

3.

Resilience: A psychobiological construct for psychiatric disorders.

Shrivastava A, Desousa A.

Indian J Psychiatry. 2016 Jan-Mar;58(1):38-43. doi: 10.4103/0019-5545.174365. Review.

4.

Suicide prevention competencies among urban Indian physicians: A needs assessment.

Eynan R, Reiss L, Links P, Shah R, Sathyanarayana Rao TS, Parkar S, Dutt L, Kadam K, De Souza A, Shrivastava A.

Indian J Psychiatry. 2015 Oct-Dec;57(4):397-402. doi: 10.4103/0019-5545.171848.

5.

Clozapine response and pre-treatment EEG-is there some kind of relationship.

Shrivastava A, Johnston M, Shah N, Stitt L, Shrivastava S, Sousa AD.

Ind Psychiatry J. 2014 Jan;23(1):18-22. doi: 10.4103/0972-6748.144951.

6.

Cannabis and psychosis: Neurobiology.

Shrivastava A, Johnston M, Terpstra K, Bureau Y.

Indian J Psychiatry. 2014 Jan;56(1):8-16. doi: 10.4103/0019-5545.124708. Review.

7.

Bereavement after the suicide of a significant other.

Pompili M, Shrivastava A, Serafini G, Innamorati M, Milelli M, Erbuto D, Ricci F, Lamis DA, Scocco P, Amore M, Lester D, Girardi P.

Indian J Psychiatry. 2013 Jul;55(3):256-63. doi: 10.4103/0019-5545.117145.

8.

Dimensions of suicidality: analyzing the domains of the SIS-MAP Suicide Risk Assessment Instrument and the development of a brief screener.

Johnston ME, Nelson C, Shrivastava A.

Arch Suicide Res. 2013;17(3):212-22. doi: 10.1080/13811118.2013.805639.

PMID:
23889571
9.

Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification.

Shrivastava A, Bureau Y, Rewari N, Johnston M.

Indian J Psychiatry. 2013 Apr;55(2):178-82. doi: 10.4103/0019-5545.111459.

10.

Polypharmacy in psychiatry: a review.

Kukreja S, Kalra G, Shah N, Shrivastava A.

Mens Sana Monogr. 2013 Jan;11(1):82-99. doi: 10.4103/0973-1229.104497.

11.

Pathways to psychosis in cannabis abuse.

Shrivastava A, Johnston M, Terpstra K, Bureau Y.

Clin Schizophr Relat Psychoses. 2015 Apr;9(1):30-5. doi: 10.3371/CSRP.SHJO.030813. Review.

PMID:
23491968
12.

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia.

Shrivastava A, Johnston M, Terpstra K, Stitt L, Shah N.

Indian J Psychiatry. 2012 Jul;54(3):248-52. doi: 10.4103/0019-5545.102425.

13.

Reducing treatment delay for early intervention: evaluation of a community based crisis helpline.

Shrivastava AK, Johnston ME, Stitt L, Thakar M, Sakel G, Iyer S, Shah N, Bureau Y.

Ann Gen Psychiatry. 2012 Jul 24;11(1):20. doi: 10.1186/1744-859X-11-20.

14.
15.

Stigma of Mental Illness-2: Non-compliance and Intervention.

Shrivastava A, Johnston M, Bureau Y.

Mens Sana Monogr. 2012 Jan;10(1):85-97. doi: 10.4103/0973-1229.90276.

16.

Stigma of Mental Illness-1: Clinical reflections.

Shrivastava A, Johnston M, Bureau Y.

Mens Sana Monogr. 2012 Jan;10(1):70-84. doi: 10.4103/0973-1229.90181.

17.

Predicting suicidality among psychiatric patients.

Shrivastava A, Johnston M, Nelson C, Lester D.

Psychol Rep. 2011 Oct;109(2):367-8.

PMID:
22238844
18.

Cannabis use and cognitive dysfunction.

Shrivastava A, Johnston M, Tsuang M.

Indian J Psychiatry. 2011 Jul;53(3):187-91. doi: 10.4103/0019-5545.86796. No abstract available.

19.

Social outcome in clinically recovered first-episode schizophrenia in a naturalistic, ten-year, follow-up study in India.

Shrivastava A, Johnston M, Thakar M, Stitt L, Shah N.

Clin Schizophr Relat Psychoses. 2011 Jul;5(2):95-101. doi: 10.3371/CSRP.5.2.6.

PMID:
21693433
20.

Persistent cognitive dysfunction despite clinical improvement in schizophrenia: a 10-year follow-up study.

Shrivastava A, Johnston M, Shah N, Thakar M, Stitt L.

J Psychiatr Pract. 2011 May;17(3):194-9. doi: 10.1097/01.pra.0000398412.67115.5c.

PMID:
21586997

Supplemental Content

Loading ...
Support Center